Exploring the Potential Drug Target ATP8B4: Unlocking the Switch for parkin gene inactivation

Target Name: ATP8B4

NCBI ID: G79895

ATP8B4

Exploring the Potential Drug Target ATP8B4: Unlocking the Switch for parkin gene inactivation

Introduction

ATP (adenylylated cyclic phosphate) is a crucial energy supplier in all living cells. It is the energy currency of the cell, and its levels directly impact the cell's energy needs. ATP is generated from the reaction of ADP (adenylylated cyclic phosphate) and phosphate , using energy from the cell's food chain. Adenosine diphosphate (ADP) is the most abundant ATP synthase enzyme, while the Parkin gene is responsible for the production of the protein Parkin, which plays a critical role in regulating ATP levels.

The Parkin gene has been associated with various neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Inactivation of the Parkin gene has been linked to the accumulation of misfolded proteins, neurodegeneration, and the progression of these disorders. Therefore, it is of great interest to investigate the role of ATPIM (ATP-dependent Immediate Market) in inactivation of the Parkin gene.

ATPIM: The Unlocking Switch for parkin Gene's Misfolding

ATPIM is a protein that is highly expressed in brain regions affected by neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. It is involved in the regulation of ATP levels and plays a crucial role in the production of ATP from ADP. The accumulation of misfolded proteins , such as Parkin, is a major contributor to the neurodegeneration observed in these diseases.

ATPIM functions as a protein-ligand for the interaction between ATP and the Parkin protein. This interaction allows ATPIM to physically interact with Parkin and prevent its misfolding. ATPIM contains a unique ATP-binding site that is specific for Parkin and allows it to efficiently bind to the protein.

The role of ATPIM in the regulation of ATP levels and the production of ATP from ADP is well established in the scientific literature. Parkin has been shown to regulate the activity of the ATPase, which is responsible for the production of ATP from ADP. The Parkin gene has also been shown to encode a protein that is involved in the regulation of ATP levels.

In addition to its role in the production of ATP, the Parkin gene has also been associated with the regulation of various cellular processes, including cell signaling, DNA replication, and metabolism. The Parkin protein has been shown to play a critical role in the regulation of the dynamics of the mitochondria, which are responsible for the production of ATP.

The Potential Role of ATPIM in Parkin Gene's Misfolding

The misfolding of proteins is a well-known phenomenon in neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The accumulation of misfolded proteins, such as Parkin, is a major contributor to the neurodegeneration observed in these diseases.

ATPIM has been shown to play a crucial role in the regulation of the misfolding of Parkin protein. Studies have shown that ATPIM can prevent the misfolding of Parkin protein and maintain its stability. This function of ATPIM is likely due to its ability to physically interact with Parkin and prevent the formation of Parkin dimers, which are known to play a key role in the misfolding of proteins.

In addition to its role in preventing the misfolding of Parkin protein, ATPIM may also be involved in the regulation of ATP levels. Studies have shown that the activity of the ATPase, which is responsible for the production of ATP from ADP, is regulated by ATPIM. This suggests that ATPIM may be involved in the regulation of ATP levels and the production of ATP from ADP.

The Potential of ATPIM as a Drug Target

The accumulation of misfolded proteins, such as Parkin, is a major contributor to the neurodegeneration observed in various neurological disorders, including Alzheimer's disease and Parkinson's disease. The regulation of

Protein Name: ATPase Phospholipid Transporting 8B4 (putative)

Functions: Component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules (Probable)

The "ATP8B4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP8B4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets